On June 11, 2025, Crinetics Pharmaceuticals, Inc. held its annual stockholders' meeting, where 95% of shares voted to elect three directors, ratify the accounting firm, and approve executive compensation. Notably, R. Scott Struthers received 69.6 million votes for his director position.